MedTrace Logo

Community Resiliency Collective Efficacy Intervention

NCT05768217 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4600

Last updated 2025-07-08

No results posted yet for this study

Summary

This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence.

Conditions

  • Violence, Physical
  • Violence, Non-accidental
  • Violence, Sexual
  • Violence, Domestic
  • Violence, Structural
  • Violence in Adolescence
  • Community Violence
  • Social Cohesion

Interventions

BEHAVIORAL

Community Resiliency Collective Efficacy Intervention (CRCEI)

The Community Resiliency Collective Efficacy Intervention (CRCEI) will involve community members in dialogue on thriving, community leadership, and organizing for social change. Participants in the intervention condition will be asked to participate in 2 sessions of discussions about community thriving and a 7-week training program on the following topics: Building on the Strengths of Your Community, Collective Efficacy and its Effects on Violence Prevention \& Community Mental Health, Non-threatening Peaceful Intervention Principles and Strategies: Part One, Non-threatening Peaceful Intervention Principles and Strategies: Part Two, Safety and Roles of Police and Community in Intervening, Active/Effective listening and non-violent communication skills, and Community Resources and Indirect Intervention.

BEHAVIORAL

Health Education Sessions

Comparison neighborhoods will receive health education sessions across a variety of community-identified health topics as a control intervention. (9 sessions)

Sponsors & Collaborators

Principal Investigators

  • Elizabeth Miller, MD, PhD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-24
Primary Completion
2026-09-30
Completion
2027-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05768217 on ClinicalTrials.gov